Publikationen von Yvonne Genzel
Alle Typen
Zeitschriftenartikel (102)
21.
Zeitschriftenartikel
105 (5), S. 1861 - 1874 (2021)
Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins. Applied Microbiology and Biotechnology 22.
Zeitschriftenartikel
95 (24), e01174-21 (2021)
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. Journal of Virology 23.
Zeitschriftenartikel
288 (16), S. 4869 - 4891 (2021)
Comprehensive N‐glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells. The FEBS Journal 24.
Zeitschriftenartikel
11 (1), 5147 (2021)
Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins. Scientific Reports 25.
Zeitschriftenartikel
105 (4), S. 1421 - 1434 (2021)
High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells. Applied Microbiology and Biotechnology 26.
Zeitschriftenartikel
8, 672 (2020)
Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode. Frontiers in Bioengineering and Biotechnology 27.
Zeitschriftenartikel
104 (11), S. 4877 - 4888 (2020)
Performance of an Acoustic Settler Versus a Hollow Fiber-Based ATF Technology for Influenza Virus Production in Perfusion. Applied Microbiology and Biotechnology 28.
Zeitschriftenartikel
117 (10), S. 3040 - 3052 (2020)
Virus harvesting in perfusion culture: Choosing the right typeof hollow fiber membrane. Biotechnology and Bioengineering 29.
Zeitschriftenartikel
21 (17), 6111 (2020)
Cell Bank Origin of MDCK Parental Cells Shapes Adaptation to Serum-Free Suspension Culture and Canine Adenoviral Vector Production. International Journal of Molecular Sciences 30.
Zeitschriftenartikel
117 (5), S. 1533 - 1553 (2020)
A dynamic model linking cell growth to intracellular metabolism and extracellular by‐product accumulation. Biotechnology and Bioengineering 31.
Zeitschriftenartikel
37 (47), S. 7003 - 7010 (2019)
Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production. Vaccine 32.
Zeitschriftenartikel
37 (47), S. 7011 - 7018 (2019)
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems. Vaccine 33.
Zeitschriftenartikel
Use of sulfated cellulose membrane adsorbers for chromatographic purification of cell cultured-derived influenza A and B viruses. Separation and Purification Technology (226), S. 350 - 358 (2019)
34.
Zeitschriftenartikel
37 (47), S. 7019 - 7028 (2019)
Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1. Vaccine 35.
Zeitschriftenartikel
7, 275 (2019)
Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling. Frontiers in Bioengineering and Biotechnology 36.
Zeitschriftenartikel
14 (11), e0224317 (2019)
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”. PLoS One 37.
Zeitschriftenartikel
103 (7), S. 3025 - 3035 (2019)
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system. Applied Microbiology and Biotechnology 38.
Zeitschriftenartikel
36 (22), S. 3140 - 3145 (2018)
Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells. Vaccine 39.
Zeitschriftenartikel
102 (20), S. 8725 - 8737 (2018)
Process intensification of EB66 ® cell cultivations leads to high-yield yellow fever and Zika virus production. Applied Microbiology and Biotechnology 40.
Zeitschriftenartikel
9, 26 (2018)
Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution. Frontiers in immunology